🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial

  2. early standardised rhythm control

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  3. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  4. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  5. ginkgolide

    The First People's Hospital of Lianyungang

    Intravenous Alteplase Thrombolysis

    approved small molecule completed

    1 trial

  6. half-dose ticagrelor

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  7. hyaluronidase (human recombinant)/rehydration fluid

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  8. hydrochloride hydromorphone + flurbiprofen axetil

    The First People's Hospital of Lianyungang

    Enhanced Recovery After Surgery

    approved small molecule completed

    1 trial

  9. hylan G-F 20

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved other completed

    1 trial

  10. hylenex-facilitated subcutaneous Lactated Ringer's infusion

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  11. iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  12. imiquimod

    United Therapeutics Europe Ltd

    Anal Dysplasia

    approved small molecule terminated

    1 trial

  13. inhaled treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    3 trials

  14. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  15. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  16. iodixanol

    The First People's Hospital of Lianyungang

    Kidney Failure, Chronic

    approved small molecule active

    1 trial

  17. iron and zinc combined

    United Therapeutics Europe Ltd

    Anemia

    approved other completed

    1 trial

  18. ketamine

    United Therapeutics Europe Ltd

    Acute Pain

    approved small molecule terminated

    1 trial

  19. large protein molecule

    HALOZYME THERAPEUTICS, INC.

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  20. lorlatinib

    The First People's Hospital of Lianyungang

    NSCLC

    approved small molecule active

    1 trial

  21. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Platelet Reactivity

    approved small molecule completed

    1 trial

  22. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    approved small molecule active

    1 trial

  23. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  24. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources